Short description
Designer of platform AI and intelligent imaging technology for automated analysis of microbiology processes.
Description
Medical technology company commercialising the first and only FDA cleared instrument using Artificial Intelligence (AI) which automates reading of culture plates in hospitals and microbiology laboratories globally. This first in class technology has US-FDA, CE Mark and TGA regulatory clearances and is available for sale in the United States, the European Union and Australia. The AI algorithm and intelligent imaging platform technology is patent protected, clinically proven through a 10,000 patient clinic trial with reference customer sites established in the US, EU and AU, with early sales.
Last funding
Nopepepe
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Adelaide, South Australia, Australia, Oceania
Founded on
January 1, 2004
Exited on
July 31, 2006
Went public on
July 31, 2006
Stock symbol
LBT
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$34056 - 789030
Sign in for full access
Founders
Lusia Guthrie